Macrocyclic β-sheet peptides that mimic protein quaternary structure through intermolecular β-sheet interactions

Journal of the American Chemical Society

Volumn 129, Issue 17, 2007, Pages 5558-5569

  Khakshoor, Omid ^a   Demeler, Borries ^b   Nowick, James S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC PEPTIDES; HEPTAPEPTIDE SEQUENCES; QUATERNARY STRUCTURE;

AMINO ACIDS; DIMERS; MOLECULAR INTERACTIONS; MOLECULAR STRUCTURE; OLIGOMERIZATION; PROTEINS;

PEPTIDES;

ALPHA AMINO ACID; AMINO ACID; CYCLOPEPTIDE; HEPTAPEPTIDE; MACROCYCLIC COMPOUND; MONOMER; OLIGOMER; ORNITHINE; PHENYLALANINE; PROTEIN; PROTEIN NUG2; TETRAMER; THREONYLSERYLPHENYLALANYLTHREONYLTYROSYLTHREONYLSERINE; TYROSINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AQUEOUS SOLUTION; ARTICLE; BETA SHEET; DIFFUSION; DIMERIZATION; HYDROPHOBICITY; MOLECULAR INTERACTION; NUCLEAR MAGNETIC RESONANCE; OLIGOMERIZATION; PEPTIDE SYNTHESIS; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN QUATERNARY STRUCTURE; PULSED ELECTRIC FIELD; ULTRACENTRIFUGATION;

CYCLIZATION; MACROCYCLIC COMPOUNDS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR MIMICRY; PEPTIDES; PROTEIN FOLDING; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; SPECTROPHOTOMETRY, ULTRAVIOLET; ULTRACENTRIFUGATION; WATER;

EID: 34247884335     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja068511u     Document Type: Article

References (108)

1. (a) Maitra, S.; Nowick, J. S. In The Amide Linkage: Structural Significance in Chemistry, Biochemistry, and Materials Science; Greenberg, A., Breneman, C. M., Liebman, J. F., Eds.; Wiley: New York, 2000; pp 495-518.
2. (b) Remaut, H.; Waksman, G. Trends Biochem. Sci. 2006, 31, 436-444.
3. Navia, M. A.; Fitzgerald, P. M. D.; McKeever, B. M.; Le, C. T.; Heimbach, J. C.; Herber, W. K.; Sigal, I. S.; Darke, P. L.; Springer, J. P. Nature 1989, 337, 615-620.
4. Nassar, N.; Horn, G.; Herrmann, C.; Scherer, A.; McCormick F.; Wittinghofer, A. Nature 1995, 375, 554-560.
5. (a) Ross, C. A.; Poirier, M. A. Nat. Med. 2004, 10 (Suppl.), S10-S17.
6. (b) Tycko, R. Curr. Opin. Struct. Biol. 2004, 14, 96-103.
7. (c) Makin O. S.; Serpell, L. C. FEBS J. 2005, 272, 5950-5961.
8. (d) Nelson, R.; Eisenberg, D. Curr. Opin. Struct. Biol. 2006, 16, 260-265.
9. (e) Chiti, F.; Dobson, C. M. Annu. Rev. Biochem. 2006, 75, 333-366.
10. (f) Wetzel, R. Acc. Chem. Res. 2006, 39, 671-679.
11. Sommers, W. S.; Phillips, S. E. V. Nature 1992, 359, 387-393.
12. Hill, C. P.; Yee, J.; Selsted, M. E.; Eisenberg, D. Science 1991, 251, 1481-1485.
13. (a) Smith, C. K.; Regan, L. Acc. Chem. Res. 1997, 30, 153-161.
14. (b) Gellman, S. H. Curr. Opin. Chem. Biol. 1998, 2, 717-725.
15. (c) Ramirez-Alvarado, M.; Kortemme, T.; Blanco, F. J.; Serrano, L. Bioorg. Med. Chem. 1999, 7, 93-103.
16. (d) Searle, M. S. J. Chem. Soc., Perkin Trans. 2 2001, 1011-1020.
17. (e) Venkatraman, J.; Shankaramma, S. C.; Balaram, P. Chem Rev. 2001, 101, 3131-3152.
18. (f) Searle, M. S.; Ciani, B. Curr. Opin. Struct. Biol. 2004, 14, 458-464.
19. (g) Hughes, R. M.; Waters, M. L. Curr. Opin. Struct. Biol. 2006, 16, 514-524.
20. For examples of large peptides that fold into larger β-sheet structures, see: (a) Pessi, A.; Bianchi, E.; Crameri, A.; Venturini, S.; Tramontano, A.; Sollazzo, M. Nature 1993, 362, 367-369.
21. (b) Quinn, T. P.; Tweedy, N. B.; Williams, R. W.; Richardson, J. S.; Richardson, D. C. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 8747-8751.
22. (c) Yan, Y. B.; Erickson, B. W. Protein Sci. 1994, 3, 1069-1073.
23. (d) Ilyina, E.; Roongta, V.; Mayo, K. H. Biochemistry 1997, 36, 5245-5250.
24. (e) Kortemme, T.; Ramirez-Alvarado, M.; Serrano, L. Science 1998, 281, 253-256.
25. (f) Schenck, H. L.; Gellman, S. H. J. Am. Chem. Soc. 1998, 120, 4869-4870.
26. (g) De Alba, E.; Santoro, J.; Rico, M.; Jiménez, M. A. Protein Sci. 1999, 8, 854-865.
27. (h) Griffiths-Jones, S. R.; Searle, M. S. J. Am. Chem. Soc. 2000, 122, 8350-8356.
28. (i) Carulla, N.; Woodward, C; Barany, G. Protein Sci. 2002, 11, 1539-1551.
29. (j) Venkatraman, J.; Gowda, G. A. N.; Balaram, P. J. Am. Chem. Soc. 2002, 124, 4987-4994.
30. (k) Neidigh, J. W.; Fesinmeyer, R. M.; Anderson, N. Nat. Struct. Biol. 2002, 9, 425-430.
31. (l) Nanda, V.; Rosenblatt, M. M.; Osyczka, A.; Kono, H.; Getahun, Z.; Dutton, P. L.; Saven, J. G.; DeGrado, W. F. J. Am. Chem. Soc. 2005, 127, 5804-5805.
32. (a) Nowick, J. S.; Smith, E. M.; Pairish, M. Chem. Soc. Rev. 1996, 401-415.
33. (b) Nowick, J. S. Acc. Chem. Res. 1999, 32, 287-296.
34. (c) Loughlin, W. A.; Tyndall, J. D. A.; Glenn, M. P.; Fairlie, D. P. Chem. Rev. 2004, 104, 6085-6117.
35. For some recent examples, see: (a) Matsumura, S.; Uemura, S.; Mihara, H. Chem. - Eur. J. 2004, 10, 2789-2794.
36. (b) Ozbas, B.; Kretsinger, J.; Rajagopal, K.; Schneider, J. P.; Pochan, D. J. Macromolecules 2004, 37, 7331-7337.
37. (c) Litvinchuk, S.; Bollot, G.; Mareda, J.; Som, A.; Ronan, D.; Shah, M. R.; Perrottet, P.; Sakai, N.; Matile, S. J. Am. Chem. Soc. 2004, 126, 10067-10075.
38. (d) Deechongkit, S.; Powers, E. T.; You, S. L.; Kelly, J. W. J. Am. Chem. Soc. 2005, 127, 8562-8570.
39. (e) Davies, R. V. P.; Aggeli, A.; Beevers, A. J.; Boden, N.; Carrick, L. M.; Fishwick, C. W. G.; McLeish, T. C. B.; Nyrkova, I.; Semenov, A. N. Supramol. Chem. 2006, 18, 435-443.
40. (f) Koga, T.; Higuchi, M.; Kinoshita, T.; Higashi, N. Chem. - Eur. J. 2006, 12, 1360-1367.
41. For some recent reviews, see: (a) Bong, D. T.; Clark, T. D.; Granja, J. R.; Ghadiri, M. R. Angew. Chem., Int. Ed. 2001, 40, 988-1011.
42. (b) Zhang, S. G. Nat. Biotechnol. 2003, 21, 1171-1178.
43. (c) Rajagopal, K.; Schneider, J. P. Curr. Opin. Struct. Biol. 2004, 14, 480-486.
44. (a) Nowick, J. S.; Tsai, J. H.; Bui, Q. C. D.; Maitra, S. J. Am. Chem. Soc. 1999, 121, 8409-8410.
45. (b) Nowick, J. S.; Chung, D. M.; Maitra, K.; Maitra, S.; Stigers, K. D.; Sun, Y. J. Am. Chem. Soc. 2000, 122, 7654-7661.
46. (c) Nowick, J. S.; Lam, K. S.; Khasanova, T. V.; Kemnitzer, W. E.; Maitra, S.; Mee, H. T.; Liu, R. J. Am. Chem. Soc. 2002, 124, 4972-4973.
47. (d) Nowick, J. S.; Chung, D. M. Angew. Chem., Int. Ed. 2003, 42, 1765-1768.
48. (e) Chung, D. M.; Nowick, J. S. J. Am. Chem. Soc. 2004, 126, 3062-3063.
49. (f) Chung, D. M.; Dou, Y.; Baldi, P.; Nowick, J. S. J. Am. Chem. Soc. 2004, 127, 9998-9999.
50. (a) Ghadiri, M. R.; Kobayashi, K.; Granja, J. R.; Chadha, R. K.; McRee, D. E. Angew. Chem., Int. Ed. Engl. 1995, 34, 93-95.
51. (b) Gong, B.; Yan, Y.; Zeng, H.; Skrzypczak-Jankunn, E.; Kim, Y. W.; Zhu, J.; Ickes, H. J. Am. Chem. Soc. 1999, 121, 5607-5608.
52. (c) Phillips, S. T.; Rezac, M.; Abel, U.; Kossenjans, M.; Bartlett, P. A. J. Am. Chem. Soc. 2002, 124, 58-66.
53. (a) Mayo, K. H.; Ilyina, E. Protein Sci. 1998, 7, 358-368.
54. Ali, M. H.; Peisach, E.; Allen, K. N.; Imperiali, B. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 12183-12188.
55. (a) Dou, Y.; Baisnée, P.-F.; Pollastri, G.; Pécout, Y.; Nowick, J.; Baldi, P. Bioinformatics 2004, 20, 2767-2777.
56. (b) http://www.igb.uci.edu/servers/icbs/.
57. Nowick, J. S.; Brower, J. O. J. Am. Chem. Soc. 2003, 125, 876-877.
58. Woods, R. J.; Brower, J. O.; Castellanos, E.; Hashemzadeh, M.; Khakshoor, 0.; Russo, W. A.; Nowick, J. S. J. Am. Chem. Soc. 2007, 129, 2548-2558.
59. For other examples of designed cyclic peptides that fold into β-sheet structures, see: (a) Spath, J.; Stuart, F.; Jiang, L.; Robinson, J. A. Helv. Chim. Acta 1998, 81, 1726-1738.
60. (b) Syud, F. A.; Espinosa, J. F.; Gellman, S. H. J. Am. Chem. Soc. 1999, 121, 11577-11578.
61. (c) Kiehna, S. E.; Waters, M. L. Protein Sci. 2003, 12, 2657-2667.
62. Other cyclic peptides containing 54-membered rings (cyclo- octadecapeptides), including naturally occurring θ-defensin, have been previously synthesized and studied. For examples, see ref 19c and (a) Ando, S.; Nishikawa, H.; Takiguchi, H.; Lee, S.; Sugihara, G. Biochim. Biophys. Acta. Biomembranes 1993, 1147, 42-49.
63. (b) Tang, Y. Q.; Yuan, J.; Ösapay, G.; Ösapay, K.; Tran, D.; Miller, C. J.; Quellette, A. J.; Selsted, M. E. Science 1999, 286, 498-502.
64. (c) Trabi, M.; Schirra, H. J.; Craik, D. J. Biochemistry 2001, 40, 4211-4221.
65. (d) Tran, D.; Tran, P. A.; Tang, Y.-Q.; Yuan, J.; Cole, T.; Selsted, M. E. J. Biol. Chem. 2002, 277, 3079-3084.
66. Nauli, S.; Kuhlman, B.; Trong, I. L.; Stenkamp, R. E.; Teller, D.; Baker, D. Protein Sci. 2002, 11, 2924-2931.
67. PS-PEG-trityl chloride resin was prepared from PS-PEG-trityl alcohol resin (Novabiochem NovaSyn TGT alcohol resin) by treatment with acetyl chloride, as described in the Novabiochem catalog.
68. 2O solution.
69. Wishart, D. S.; Sykes, B. D. Methods Enzymol. 1994, 239, 363-392.
70. α values (average of 0.05 ppm) than those of peptide 6 (Figure 3). This slight downfield shifting of the peptide 3a monomer suggests a somewhat greater population of β-strand conformer.
71. NOEs among side chains that might arise from further self-association of the dimers cannot be distinguished from those resulting from folding and dimerization.
72. For an introduction to PFG NMR, see: (a) Price, W. S. Concepts Magn. Reson. 1997, 9, 299-336.
73. (b) Price, W. S. Concepts Magn. Reson. 1998, 10, 197-237.
74. (c) Johnson, C. S. Progr. NMR Spectrose 1999, 34, 203-256.
75. (a) Altieri, A. S.; Hinton, D. P.; Byrd, R. A. J. Am. Chem. Soc. 1995, 117, 7566-7567.
76. (b) Yao, S.; Howlett, G. J.; Norton, R. S. J. Biomol. NMR 2000, 16, 109-119.
77. (c) Cohen, Y.; Avram, L.; Frish, L. Angew. Chem., Int. Ed. 2005, 44, 520-554.
78. Exchange between the monomer and the oligomer occurs relatively slowly, on the time scale of the PFG NMR experiment, and has little effect on the diffusion coefficients observed for either species.
79. (a) Ilyina, E.; Roongta, V.; Pan, H.; Woodward, C; Mayo, K. H. Biochemistry 1997, 36, 3383-3388.
80. (a) Longsworfh, L. G. J. Phys. Chem. 1954, 58, 770-773.
81. (b) Barshtein, G.; Almagor, A.; Yedgar, S.; Gavish, B. Phys. Rev. E 1995, 52, 555-557.
82. Teller, D. C.; Swanson, E.; DeHaen, C. Methods Enzymol. 1979, 61, 103-124.
83. Poison, A. J. Phys. Colloid Chem. 1950, 54, 649-652.
84. (a) Ralston, G. Introduction to Analytical Ultracentrifugation; Beckman Instruments, Inc.: Fullerton, CA, 1993.
85. (b) McRorie, D. K.; Voelker, P. J. Self-Associating Systems in the Analytical Ultracentrifugation; Beckman Instruments, Inc.: Palo Alto, CA, 1993.
86. (c) Howlett, G. J.; Minton, A. P.; Rivas, G. Curr. Opin. Chem. Biol. 2006, 10, 430-436.
87. 2O solution without NaCl. This result indicates that the oligomerization states do not change upon adding NaCl.
88. (a) Durchschlag, H. In Thermodynamic Data for Biochemistry and Biotechnology; Hinz, H.-J., Ed.; Springer-Verlag: New York, 1986; pp 45-128.
89. (b) Durchschlag, H.; Zipper, P. Progr. Colloid Polym. Sci. 1994, 94, 20-39.
90. 3/g according to ref 36b.
91. (a) Demeler, B. In Modern Analytical Ultracentrifugation: Techniques and Methods; Scott, D. J., Harding, S. E., Rowe, A. J., Eds.; Royal Society of Chemistry: U.K., 2005; pp 210-229.
92. (b) http://www.ultrascan.uthscsa.edu.
93. Demeler, B.; Van Holde, K. E. Anal. Biochem. 2004, 335, 279-288.
94. Finite element analysis of the data from the 39 μM experiment suggests that this peak corresponds to the monomer. For a description of finite element analysis, see: (a) Cao, W.; Demeler, B. Biophys. J. 2005, 89, 1589-1602.
95. (b) Demeler, B.; Saber, H. Biophys. J. 1998, 74, 444-454.
96. Johnson, M. L.; Correia, J. J.; Yphantis, D. A.; Halvorson, H. R. Biophys. J. 1981, 36, 575-588.
97. The UV-absorbance data from the 15 μM samples (g and h) are scaled to fringes and appear relatively shallow because they are plotted on the same scale as the data from the 1.5 and 9 mM experiments.
98. Foss, T. R.; Kelker, M. S.; Wiseman, R. L.; Wilson, I. A.; Kelly, J. W. J. Mol. Biol. 2005, 347, 841-854.
99. Hagihara, Y.; Oobatake, M.; Goto, Y. Protein Sci. 1994, 3, 1418-1429.
100. The ionization state of the GIu residue in peptides 3b and 3h is not certain, because the studies were done without buffer. Attempts to control the pH with phosphate buffer resulted in precipitation of these peptides.
101. 2/s, respectively, which are about the same as those values for the monomer and tetramer of peptide 3a. The ratio of these values (0.57) is consistent with tetramer formation.
102. 2/s, which is about the same as that of the tetramer of peptide 3a at the same temperature.
103. The diffusion coefficients of the oligomers of peptides 3j and 3k are about 0.80-0.85 times that of the tetramer of peptide 3a. The smaller diffusion coefficients of these peptides suggest that peptides 3j and 3k form higher oligomers, such as hexamers or octamers, rather than tetramers. ROESY experiments show that the oligomers of these peptides comprise edge-to-edge dimers. The higher oligomers may be thought of as small micelles in which the hydrophobic faces of the β-sheet dimers form a hydrophobic core.
104. We have observed similar improvements in the folding of the 42-membered-ring macrocyclic peptides 2 upon placing Phe across from the aromatic ring of Hao. For details, see ref 18.
105. Wuthrich, K. NMR of Proteins and Nucleic Acids; Wiley: New York, 1986; p 17.
106. 2O solution of peptide 3m from 1.0 mM to 16.0 mM results in similar downfield shifting.
107. For a notable exception, see: (a) Li, H.; Dunn, J. J.; Luft, B. J.; Lawson, C. L. Proc Natl. Acad. Sci. U.S.A. 1997, 94, 3584-3589.
108. (b) Koide, S.; Huang, X.; Link, K.; Koide, A.; Bu, Z.; Engelman, D. M. Nature 2000, 403, 456-460.